1/13
08:00 am
algs
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
Medium
Report
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
1/9
06:10 am
algs
Aligos Therapeutics (NASDAQ:ALGS) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
High
Report
Aligos Therapeutics (NASDAQ:ALGS) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
09:53 am
algs
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely [Yahoo! Finance]
Medium
Report
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely [Yahoo! Finance]
1/7
03:00 am
algs
Aligos Therapeutics (NASDAQ:ALGS) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
High
Report
Aligos Therapeutics (NASDAQ:ALGS) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
12/12
08:00 am
algs
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/11
08:27 am
algs
Aligos Therapeutics Presents Positive Data at HEP-DART 2025 [Yahoo! Finance]
Low
Report
Aligos Therapeutics Presents Positive Data at HEP-DART 2025 [Yahoo! Finance]
12/11
08:00 am
algs
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
Medium
Report
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
11/14
08:00 am
algs
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/10
08:40 am
algs
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 [Yahoo! Finance]
11/10
08:00 am
algs
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
Low
Report
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
11/8
01:12 am
algs
Aligos Therapeutics (NASDAQ:ALGS) was downgraded by analysts at
Wall Str
Low
Report
Aligos Therapeutics (NASDAQ:ALGS) was downgraded by analysts at
Wall Str
11/6
08:30 am
algs
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
Low
Report
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
11/4
08:30 am
algs
Aligos Therapeutics to Present at Upcoming Investor Conferences
Medium
Report
Aligos Therapeutics to Present at Upcoming Investor Conferences
10/30
08:30 am
algs
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
Medium
Report
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025